Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study
DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ...
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria ...
T-Net7d
Kelowna-based Lexaria Closes $5 Million Financing via Private Placement (Registered Direct Offering)
Bioscience Corp. (Nasdaq:LEXX; LEXXW), a developer of drug delivery platforms, today announced that it has closed a ...
Investing2d
Lexaria reports advances in weight loss drug study
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Yahoo Finance8d
Companies Like Lexaria Bioscience (NASDAQ:LEXX) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. By way of example, Lexaria Bioscience (NASDAQ:LEXX) has seen its share price rise 199% over the last year, ...
Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Teva Pharmaceuticals (NYSE:TEVA) on June 24, 2024, announced the authorized launch of a generic version of Novo Nordisk's Victoza® as injected liraglutide and noted that Victoza had annual sales of $1 ...
Morningstar8d
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has ...
Investing2d
Lexaria reports advances in weight loss drug study
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...
Stockhouse3d
Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) in DehydraTECH compositions - Recalculations led to slight changes from earlier reported data Lexaria is strongly ...
PharmiWeb9d
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has ...
Nasdaq9d
Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that ...
Lexaria Bioscience Corp.: Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has clo ...